‘Keytruda’ administration test method accepted as new medical technology

A diagnostic check method which is used to decide administration of ‘Keytruda(pembrolizumab),’ an immunotherapy which attracted interests over the health insurance benefit, will be accepted as a new medical technology.

On the 6^th, the Ministry of Health and Welfare(MOHW) gave an administrative notice of the Partial Amendment including the contents based on the new medical technology’s safety a...